Iraq vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 15-59
Iraq
53.2%
in 2021
Kyrgyzstan
52.4%
in 2021
Iraq rank
95th
Kyrgyzstan rank
97th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Iraq
- Kyrgyzstan
How they compare
Iraq currently reports 53.2% against 52.4% in Kyrgyzstan, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Kyrgyzstan ahead.
Iraq ranks 95th and Kyrgyzstan ranks 97th of 185 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.5% | 64.9% | 10.4% | Kyrgyzstan |
| 2010s | 47.8% | 72.3% | 24.4% | Kyrgyzstan |
| 2020s | 51.2% | 54.5% | 3.3% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Iraq or Kyrgyzstan?
- Iraq, at 53.2% against 52.4% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Iraq and Kyrgyzstan?
- 0.8%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Iraq and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Iraq ranks 95th and Kyrgyzstan ranks 97th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.